Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

GEM-132 enters clinic in U.S.

Jan. 24, 1997

FDA expands orphan drug designation for NTZ

Jan. 23, 1997

NIH continues pivotal HIV-IG trial

Jan. 23, 1997

Another clinical trial on PRO-2000 begins

Jan. 22, 1997

GS-840 progresses through clinical trials

Jan. 21, 1997

Allelix refocuses drug development program

Jan. 21, 1997

Viracept licensed to Roche

Jan. 21, 1997

Triangle reports preliminary clinical results with anti-HIV compound

Jan. 20, 1997

NCI study indicates potential teratogenicity of AZT

Jan. 20, 1997

Hybridon to begin French clinical trials on anti-CMV antisense compound

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...